A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma

UZ Gasthuisberg, Leuven

Cliniques Universitaires UCL de Mont-Goddine, Yvoir

Weill Cornell Medical College, New York

Memorial Sloan Kettering Cancer Center, New York

Institut Paoli Calmettes, Marseille

University of Rochester Medical Center, Rochester

Georgetown University, Washington D.C.

University of Miami, Miami

Instituto di Ematologia ed Oncologia Medica, Bologna

Ohio State University, Columbus

Karmanos Cancer Institute, Detroit

Mayo Clinic Rochester, Rochester

Loyola University Medical Center Cardinal Bernardin Cancer Center, Maywood

Washington University School of Medicine, St Louis

Baylor Sammons Cancer Center, Dallas

Hospital Saint Louis, Paris

Centre Henri Becquerel, Rouen

Rocky Mountain Cancer Center, Denver

University of California at Los Angeles, Los Angeles

Stanford University Medical Center, Palo Alto

Oregon Health & Science University, Portland

University of Washington, Seattle

University of Alabama at Birmingham, Birmingham

City of Hope National Medical Center, Duarte

University of Texas MD Anderson Cancer Center, Houston

B.C Cancer Agency, Vancouver

Princess Margaret Hospital, Toronto